Polly A. Murphy - 16 Jun 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Polly A. Murphy
Issuer symbol
AVIR
Transactions as of
16 Jun 2024
Transactions value $
$0
Form type
4
Filing time
18 Jun 2024, 17:00:14 UTC
Previous filing
06 Jun 2024
Next filing
21 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Options Exercise $0 +33.2K +142.31% $0.00 56.4K 16 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Restricted Stock Units Options Exercise $0 -33.2K -100% $0.00* 0 16 Jun 2024 Common Stock 33.2K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 The restricted stock unites are fully vested.
F3 The restricted stock units do not have an expiration date.